United States · FDA National Drug Code directory
Bromocriptine mesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-110_98e43e82-81ff-465b-a27d-f620b182705c
- Product NDC
- 68382-110
- Form
- CAPSULE
- Composition / generic term
- Bromocriptine mesylate
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090123
- Source listing expiry
- 20271231
Source-listed ingredients
- BROMOCRIPTINE MESYLATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (68382-110-01) · 68382-110-01
- 30 CAPSULE in 1 BOTTLE (68382-110-06) · 68382-110-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →